{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Wang Y"],"funding":["Natural Science Foundation of Beijing Municipality","National Natural Science Foundation of China"],"pagination":["1144532"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10086366"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14"],"pubmed_abstract":["<h4>Introduction</h4>Aquaporin-4 immunoglobulin G (AQP4-IgG)-induced astrocytes injury is a key mechanism in the pathogenesis of neuromyelitis spectrum disorder (NMOSD), and although CCL2 is involved, its specific role has not been reported. We aimed to further investigate the role and potential mechanisms of CCL2 in AQP4-IgG-induced astrocyte injury.<h4>Methods</h4>First, we evaluated CCL2 levels in paired samples of subject patients by automated microfluidic platform, Ella®. Second, we knock down astrocyte's CCL2 gene in vitro and in vivo to define the function of CCL2 in AQP4-IgG-induced astrocyte injury. Third, astrocyte injury and brain injury in live mice were assessed by immunofluorescence staining and 7.0T MRI, respectively. Western blotting and high-content screening were conducte"],"journal":["Frontiers in immunology"],"pubmed_title":["Targeting chemoattractant chemokine (C-C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders."],"pmcid":["PMC10086366"],"funding_grant_id":["7212030","82271374"],"pubmed_authors":["Geng X","Yao M","Cong H","Bian J","Wang H","Wei Y","Zhang X","Wang Y","Du L","Xu W","Yin L","Chang H","Xu Y"],"additional_accession":[]},"is_claimable":false,"name":"Targeting chemoattractant chemokine (C-C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders.","description":"<h4>Introduction</h4>Aquaporin-4 immunoglobulin G (AQP4-IgG)-induced astrocytes injury is a key mechanism in the pathogenesis of neuromyelitis spectrum disorder (NMOSD), and although CCL2 is involved, its specific role has not been reported. We aimed to further investigate the role and potential mechanisms of CCL2 in AQP4-IgG-induced astrocyte injury.<h4>Methods</h4>First, we evaluated CCL2 levels in paired samples of subject patients by automated microfluidic platform, Ella®. Second, we knock down astrocyte's CCL2 gene in vitro and in vivo to define the function of CCL2 in AQP4-IgG-induced astrocyte injury. Third, astrocyte injury and brain injury in live mice were assessed by immunofluorescence staining and 7.0T MRI, respectively. Western blotting and high-content screening were conducte","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2025-04-19T22:09:05.73Z","creation":"2024-12-04T02:54:06.675Z"},"accession":"S-EPMC10086366","cross_references":{"pubmed":["37056770"],"doi":["10.3389/fimmu.2023.1144532"]}}